EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanism of inhibition of acid-mediated transthyretin aggregation by designed peptides

Xun Sun, Rose Pedretti, H Jane Dyson, Lorena Saelices, Peter E Wright

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Xun Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, Ca…. Hauptthemen laut MEDLINE: Prealbumin, Peptides, Protein Aggregates. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aggregation of transthyretin (TTR) causes TTR cardiomyopathy and polyneuropathy through amyloidosis. To initialize TTR aggregation, the native TTR tetramer first dissociates to a monomeric intermediate, which misfolds and self-assembles to oligomers, eventually forming insoluble aggregates and fibrils. Peptide inhibitors have been designed to cap two β-strands that are buried in the well-folded tetramer but are solvent-exposed in the monomeric aggregation intermediate. However, how these peptides affect the reaction kinetics of individual steps in the multi-step TTR aggregation pathway remains unknown. Here, we integrated 19F-NMR and kinetic modeling to determine aggregation reaction rates of individual steps with the peptide inhibitors and extract the free energy landscape along the TTR aggregation pathway. We found direct kinetic evidence that the peptide inhibitors bind to monomeric intermediates and misfolded tetramers at acidic pH, but do not bind to structured TTR monomers or tetramers at neutral pH. In addition, the peptides do not bind to amorphous aggregates formed at acidic pH and physiological temperature in vitro, in contrast to the previously reported findings that these peptides recognize ex vivo TTR fibrils derived from patients with TTR amyloidosis. Interestingly, the peptides bind to soluble oligomers formed at acidic pH and low temperature in vitro, suggesting that these oligomers may share structural similarity with misfolded monomeric intermediates and patient-derived TTR fibrils. Our methods provide quantitative and mechanistic details for peptide-inhibited TTR aggregation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrealbuminPeptidesProtein AggregatesHumansHydrogen-Ion ConcentrationKinetics

Stichwörter der Autor:innen

aggregation inhibitoraggregation kineticsaggregation mechanismamyloidreal-time (19)F-NMRtransthyretin aggregation

Substanzen

PrealbuminPeptidesProtein AggregatesTTR protein, human

Autor:innen und Institutionen

  • Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California, USA.
  • Center for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr Brain Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California, USA. Electronic address: wright@scripps.edu.

Förderung

  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • NIH National Institute of General Medical Sciences
  • University of Texas Southwestern Medical Center
  • National Institutes of Health
  • AstraZeneca

Zitieren

APA

Sun, X., Pedretti, R., Dyson, H. J., Saelices, L., & Wright, P. E. (2025). Mechanism of inhibition of acid-mediated transthyretin aggregation by designed peptides. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110594

Vancouver

Sun X, Pedretti R, Dyson HJ, Saelices L, Wright PE. Mechanism of inhibition of acid-mediated transthyretin aggregation by designed peptides. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110594

BibTeX
@article{Sun2025,
  author = {Sun, Xun and Pedretti, Rose and Dyson, H Jane and Saelices, Lorena and Wright, Peter E},
  title = {Mechanism of inhibition of acid-mediated transthyretin aggregation by designed peptides},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110594}
}
Kostenlos starten →